Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMXCP.L Regulatory News (MXCP)

  • There is currently no data for MXCP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Pre-close Trading Update

9 Sep 2019 07:00

RNS Number : 5794L
MXC Capital Limited
09 September 2019
 

 

The information contained within this announcement is deemed by the Company to constitute inside information stipulated under the Market Abuse Regulation (EU) No. 596/2014. Upon the publication of this announcement via the Regulatory Information Service, this inside information is now considered to be in the public domain.

 

 

MXC Capital Limited

("MXC" or the "Company")

 

Pre-close Trading Update, Proposed Demerger of Transactional Businesses and Proposed Tender Offer

 

MXC (AIM: MXCP), the technology focused adviser and investor, is pleased to provide an update on trading for the year ended 31 August 2019 and other corporate matters.

 

Financial Summary

 

The Company expects to report a profit at Trading EBITDA level1 of no less than £1.7m for the year (2018: loss of £1.2 million). This return to trading profit has been delivered as a result of the combination of management fees from the joint venture with Liberty Global plc ("LGJV") and the partnership with Ravenscroft Limited to advise the GIF Technology & Innovation Cell (the "GIF") in addition to transaction and consultancy fees and loan interest. These revenue streams have continued into the current year.

 

The Company confirms that as at 31 August 2019 it had an unaudited Net Asset Value2 ("NAV") of 116 pence per share (31 August 2018: 95 pence per share) with the underlying portfolio and liquid assets3 valued at 103 pence per share (31 August 2018: 80.5 pence per share). Cash as at 31 August 2019 amounted to £21.5 million. The Company has a strong pipeline of investment opportunities and expects that the majority of the cash will be invested within the next few months.

 

Progress with Investments

 

In terms of our quoted investments, both Adept4 plc ("AD4") and IDE Group Holdings plc ("IDE") have stabilised and have begun their journey of recovering the previously lost value.

 

With respect to our partnerships, LGJV successfully completed two additional transactions and now has a solid platform of monthly profitability. Additional deals continue to be reviewed. The GIF is substantially invested with a current pipeline that should see the fund fully invested or committed by the end of this calendar year. Dialogue has commenced with the shareholders of the GIF about a follow-on fund leading to potential further management fees in the future.

 

Proposed Demerger of Transactional Businesses

 

In September 2018, MXC announced the sale of 25% of the issued share capital of MXC Capital UK Limited ("MXCUK") to Ravenscroft Holdings Limited which valued the division at £9 million. MXCUK is a subsidiary of MXC and is the holding company of the Group's transactional businesses which receive the management, transactional and consultancy fees generated by the Group. The value of this division is not fully reflected in MXC's NAV and hence the Board is proposing to demerge this business into a new company and list this company on The International Stock Exchange in Guernsey ("TISE"). Should the proposed demerger be approved by shareholders, all existing shareholders in MXC will receive their pro-rata allocation of shares in the new company and its shares will be able to be traded on TISE. It is anticipated that the demerged business will be dividend paying. A circular will be sent to shareholders in due course with further details about the proposed demerger and subsequent listing on TISE and requesting shareholder approval.

 

Proposed Tender Offer

 

MXC is pleased to announce that the Board has decided to reward shareholder loyalty by reviving its policy of returning capital to shareholders. The Board's intention is to establish a progressive policy which will see capital being returned to shareholders by way of periodic tender offers. The mechanism of a tender offer gives shareholders the flexibility to either realise a return by allowing the Company to purchase a portion of their shares for cash, or to retain a potentially larger relative holding in the Company so that they might further benefit from any future capital growth. The proposed amount for this year's tender offer is equivalent to the trading profit for the Group, being £1.7 million, and, subject to shareholder approval, is expected to be paid out in October this year. The price for the tender offer will be 116 pence per share, being the NAV per share as at 31 August 2019. A circular will be sent to shareholders giving further detail of the proposed tender offer and the expected timetable shortly.

 

Peter Rigg, Chairman of MXC, commented:

 

"The year to 31 August 2019 saw significant progress for MXC both in terms of trading profitability and with respect to its investments. Post a couple of difficult years, I am delighted that the hard work of the MXC team is paying off and that we can reward shareholders for their loyalty by way of a return of capital. Furthermore, the Board believes that the proposed demerger of the Group's transactional businesses into a separate listed company will give shareholders the opportunity to benefit from the value in these businesses which is currently not fully recognised in MXC's NAV or its share price. We look forward to the coming years with confidence."

 

 

1 earnings from trading activities before interest payable, tax, depreciation, amortisation, non-recurring and exceptional items, share-based payments and movements in fair value of investments and after interest income under the effective interest method as this is considered to be part of the trading activities of the Group

2 total balance sheet net assets plus market value of shares held in the Employee Benefit Trust as at 31 August 2019

3 comprises cash balances, investments, outstanding loan capital and accrued interest and the market value of shares held in the Employee Benefit Trust as at 31 August 2019

 

MXC Capital Limited

Ian Smith

+44 (0) 20 7965 8149

Zeus Capital Limited (Nominated adviser and broker)

Nick Cowles, Dan Bate

+44 (0) 161 831 1512

About MXC Capital Limited www.mxccapital.com

MXC is a specialist technology adviser and investor with a track record of investing in and advising companies in the TMT sector. MXC brings together a deep knowledge of technology, first-hand experience of managing companies in the sector, an ability to make meaningful investments and a highly experienced corporate advisory team in support, all of which combine to grow shareholder value.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTSSLFDWFUSELU
Date   Source Headline
20th Aug 20185:10 pmRNSSale of Castleton Shares
14th Aug 20187:00 amRNSConversion of Loan Notes in Castleton Technology
6th Aug 20181:30 pmRNSHolding(s) in Company
6th Aug 20181:30 pmRNSHolding(s) in Company
6th Aug 20187:00 amRNSFurther Investment / Sale of Shares
31st Jul 20187:00 amRNSProposed investment in IDE Group Holdings
19th Jul 20187:00 amRNSAcquisition by Ravenscroft of 25% shareholding
21st Jun 20188:25 amRNSHolding(s) in Company
21st Jun 20187:56 amRNSSale of Castleton Shares
12th Jun 201810:18 amRNSIssue of Equity / Total Voting Rights
30th May 20187:00 amRNSSubscription for Loan Notes in IDE Group Holdings
9th May 20187:00 amRNSInterim Results
23rd Apr 20187:00 amRNSFirst Investment into Joint Venture Liberty Global
11th Apr 20181:46 pmRNSPurchase of IDE Shares
10th Apr 20187:00 amRNSSale of Castleton Shares
21st Feb 20187:00 amRNSExercise of Castleton Option
16th Feb 20187:00 amRNSAppointed consultant to Ravenscroft Limited
13th Feb 20181:54 pmRNSResult of AGM
29th Jan 20187:00 amRNSPosting of Annual Report and Accounts
4th Dec 20177:00 amRNSBoard Change
4th Dec 20177:00 amRNSFinal Results for the Year Ended 31 August 2017
22nd Nov 20174:40 pmRNSSecond Price Monitoring Extn
22nd Nov 20174:35 pmRNSPrice Monitoring Extension
21st Nov 20172:36 pmRNSIssue of Equity / Total Voting Rights
20th Nov 20177:00 amRNSJoint Venture with Liberty Global
3rd Nov 201712:54 pmRNSNotice of Annual Results
21st Sep 20172:02 pmRNSHolding(s) in Company
25th Aug 201710:20 amRNSTransaction in Own Shares / Total Voting Rights
1st Aug 20177:00 amRNSResignation as Financial Adviser to CORETX
30th Jun 20174:19 pmRNSTransaction in Own Shares / Total Voting Rights
30th Jun 201710:15 amRNSTransaction in Own Shares / Total Voting Rights
28th Jun 20171:56 pmRNSTransaction in Own Shares / Total Voting Rights
27th Jun 20175:13 pmRNSTransaction in Own Shares / Total Voting Rights
26th Jun 201711:48 amRNSTransaction in Own Shares / Total Voting Rights
23rd Jun 20174:23 pmRNSTransaction in Own Shares / Total Voting Rights
23rd Jun 201711:36 amRNSTransaction in Own Shares / Total Voting Rights
21st Jun 20173:28 pmRNSTransaction in Own Shares / Total Voting Rights
21st Jun 201712:41 pmRNSTransaction in Own Shares / Total Voting Rights
15th Jun 20174:17 pmRNSTransaction in Own Shares / Total Voting Rights
13th Jun 20179:30 amRNSTransaction in Own Shares / Total Voting Rights
9th Jun 20171:42 pmRNSTransaction in Own Shares/ Total Voting Rights
8th Jun 20175:18 pmRNSTransaction in Own Shares/ Total Voting Rights
6th Jun 20174:22 pmRNSTransaction in Own Shares / Total Voting Rights
5th Jun 20174:33 pmRNSTransaction in Own Shares / Total Voting Rights
31st May 20175:27 pmRNSTransaction in own shares/Total voting rights
31st May 20179:46 amRNSTransaction in Own Shares/ Total Voting Rights
25th May 20174:20 pmRNSTransaction in Own Shares / Total Voting Rights
24th May 20174:14 pmRNSTransaction in Own Shares
24th May 201710:17 amRNSTransaction in Own Shares / Total Voting Rights
22nd May 20176:11 pmRNSTransaction in Own Shares / Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.